631222607	631222607	CD	B-NP	O
|	|	NN	I-NP	O
FMC	FMC	NN	I-NP	O
|	|	NN	I-NP	O
42971652	42971652	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0245714	0245714	CD	B-NP	O
|	|	CC	I-NP	O
10/21/2004	10/21/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
NON	NON	NNP	I-NP	I-protein
ST	ST	NNP	I-NP	I-protein
EVEVATION	EVEVATION	NNP	I-NP	I-protein
MYOCARDIAL	MYOCARDIAL	NNP	I-NP	I-protein
INFARCTION	INFARCTION	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/21/2004	10/21/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/6/2004	10/6/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
EMILIO	EMILIO	NNP	B-NP	O
R.	R.	NNP	I-NP	O
WAX	WAX	NNP	I-NP	O
MD	MD	NNP	I-NP	O
,	,	,	O	O
PHD	PHD	NNP	B-NP	O
ATTENDING	ATTENDING	NNP	I-NP	O
:	:	:	O	O
Shawn	Shawn	NNP	B-NP	O
Korzenski	Korzenski	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Non-ST	Non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Thromboembolic	Thromboembolic	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
occlusion	occlusion	NN	I-NP	O
,	,	,	O	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
with	with	IN	B-PP	O
St.	St.	NNP	B-NP	O
Jude	Jude	NNP	I-NP	O
's	's	POS	B-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
tricuspid	tricuspid	JJ	I-NP	I-protein
repair	repair	NN	I-NP	I-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
esophageal	esophageal	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
,	,	,	O	O
osteoporosis	osteoporosis	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
brief	brief	NN	B-NP	O
,	,	,	O	O
Ms.	Ms.	NNP	B-NP	O
Bernotas	Bernotas	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
63-year-old	63-year-old	JJ	I-NP	O
Hindi	Hindi	NNP	I-NP	O
speaking	speaking	NN	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
A.	A.	NN	B-NP	B-protein
fib	fib	NN	I-NP	I-protein
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
subacute	subacute	JJ	B-NP	O
bacterial	bacterial	JJ	I-NP	O
endocarditis	endocarditis	NN	I-NP	O
transferred	transfer	VBN	B-VP	O
from	from	IN	B-PP	O
Digua	Digua	NNP	B-NP	O
Leahem	Leahem	NNP	I-NP	O
Valley	Valley	NNP	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
64	64	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
presented	present	VBN	I-VP	O
with	with	IN	B-PP	O
several	several	JJ	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
neck	neck	NN	B-NP	O
and	and	CC	O	O
back	back	JJ	B-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
some	some	DT	B-NP	O
vague	vague	JJ	I-NP	B-protein
mild	mild	JJ	I-NP	I-protein
left	left	JJ	I-NP	I-protein
sided	sided	JJ	I-NP	I-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

No	No	DT	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
diaphoresis	diaphoresis	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
Virg	Virg	NNP	B-NP	O
Seum	Seum	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
EKG	EKG	NNP	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
with	with	IN	B-PP	O
some	some	DT	B-NP	O
1-2	1-2	CD	I-NP	O
mm	mm	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
through	through	IN	B-PP	O
V5	V5	NN	B-NP	B-protein
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
dig	dig	NN	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
demonstrated	demonstrate	VBD	B-VP	O
a	a	DT	B-NP	O
right	right	RB	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
and	and	CC	I-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Lovenox	Lovenox	NNP	B-NP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
DNMH	DNMH	NN	B-NP	O
for	for	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
CAD	CAD	NN	B-NP	O
,	,	,	O	O
rheumatic	rheumatic	JJ	B-NP	O
heart	heart	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
,	,	,	O	O
A.	A.	NN	B-NP	B-protein
fib	fib	NN	I-NP	I-protein
,	,	,	O	O
SBE	SBE	NN	B-NP	B-DNA
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBN	B-VP	O
again	again	RB	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
with	with	IN	B-PP	O
elevated	elevated	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
catheterization	catheterization	NN	I-NP	O
just	just	RB	B-NP	O
two	two	CD	I-NP	O
years	year	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
unclear	unclear	JJ	B-ADJP	O
whether	whether	IN	B-SBAR	O
or	or	CC	O	O
not	not	RB	O	O
her	her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	O
leak	leak	NN	I-NP	O
was	be	VBD	B-VP	O
from	from	IN	B-PP	O
epicardial	epicardial	JJ	B-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
or	or	CC	B-PP	O
from	from	IN	B-PP	O
another	another	DT	B-NP	O
source	source	NN	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
pericarditis	pericarditis	NN	B-NP	O
or	or	CC	I-NP	O
erosion	erosion	NN	I-NP	O
from	from	IN	B-PP	O
endocarditis	endocarditis	NN	B-NP	O
into	into	IN	B-PP	O
her	her	PRP$	B-NP	O
myocardium	myocardium	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
given	give	VBN	B-PP	O
the	the	DT	B-NP	O
back	back	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
aortic	aortic	JJ	B-NP	O
dissection	dissection	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
chest	chest	NN	I-NP	O
CT	CT	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
8/4/04	8/4/04	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
dissection	dissection	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
beta-blocker	beta-blocker	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
restarted	restart	VBN	I-VP	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
,	,	,	O	O
by	by	IN	B-PP	O
her	her	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-protein
.	.	.	O	O

Given	Give	VBN	B-VP	O
her	her	PRP$	B-NP	O
continued	continued	JJ	I-NP	O
neck	neck	NN	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
endemic	endemic	JJ	B-NP	O
ST	ST	NN	I-NP	O
changes	change	NNS	I-NP	O
which	which	WDT	B-NP	O
included	include	VBD	B-VP	O
depressions	depression	NNS	B-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
through	through	IN	B-PP	O
V5	V5	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
substantial	substantial	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
troponin	troponin	NN	I-NP	B-protein
I	I	CD	I-NP	I-protein
to	to	TO	B-PP	O
a	a	DT	B-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
64	64	CD	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
that	that	WDT	B-NP	O
demonstrated	demonstrate	VBD	B-VP	O
thrombosis	thrombosis	NN	B-NP	O
on	on	IN	B-PP	O
OM2	OM2	NN	B-NP	B-DNA
at	at	IN	B-PP	O
the	the	DT	B-NP	O
ostia	ostia	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
embolic	embolic	JJ	B-ADJP	O
.	.	.	O	O

All	All	DT	B-NP	O
her	her	PRP$	I-NP	O
other	other	JJ	I-NP	O
coronary	coronary	JJ	I-NP	O
arteries	artery	NNS	I-NP	O
appeared	appear	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
,	,	,	O	O
so	so	RB	B-ADVP	O
this	this	DT	B-NP	O
100	100	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
was	be	VBD	B-VP	O
angioplastied	angioplastie	VBN	I-VP	O
to	to	TO	B-PP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
residual	residual	NN	I-NP	O
.	.	.	O	O

Post	Post	JJ	B-NP	O
procedure	procedure	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
with	with	IN	B-PP	O
rising	rise	VBG	B-NP	O
O2	O2	NN	I-NP	O
requirement	requirement	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
well	well	RB	B-ADVP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
to	to	TO	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
satting	satte	VBG	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
again	again	RB	B-ADVP	O
had	have	VBD	B-VP	O
neck	neck	NN	B-NP	O
pain	pain	NN	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
through	through	IN	B-PP	O
V5	V5	NN	B-NP	O
depressions	depression	NNS	I-NP	O
on	on	IN	B-PP	O
6/17	6/17	CD	B-NP	O
,	,	,	O	O
just	just	RB	B-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
3/25	3/25	CD	B-NP	O
This	This	DT	O	O
was	be	VBD	B-VP	O
medically	medically	RB	I-VP	O
managed	manage	VBN	I-VP	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
dynamic	dynamic	JJ	I-NP	O
changes	change	NNS	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
return	return	VB	I-VP	O
and	and	CC	O	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
left	leave	VBN	I-VP	O
over	over	IN	B-PP	O
plaque	plaque	NN	B-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
for	for	IN	B-PP	O
about	about	RB	B-NP	O
one	one	CD	I-NP	O
week	week	NN	I-NP	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
neck	neck	NN	B-NP	O
pain	pain	NN	I-NP	O
whatsoever	whatsoever	RB	B-ADVP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
troponins	troponin	NNS	I-NP	O
had	have	VBD	B-VP	O
trended	trend	VBN	I-VP	O
down	down	RB	B-ADVP	O
significantly	significantly	RB	I-ADVP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
event	event	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
complained	complain	VBN	I-VP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
while	while	IN	B-SBAR	O
walking	walk	VBG	B-VP	O
.	.	.	O	O

Pump-wise	Pump-wise	JJ	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
echo	echo	NN	I-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	B-protein
of	of	IN	B-PP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
preserved	preserve	VBN	B-NP	O
LV	LV	NN	I-NP	O
and	and	CC	I-NP	O
RV	RV	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
old	old	JJ	I-NP	O
RVSP	RVSP	NN	I-NP	O
increased	increase	VBD	B-VP	O
roughly	roughly	RB	B-ADVP	O
to	to	TO	B-PP	O
65	65	CD	B-NP	O
,	,	,	O	O
possible	possible	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
gradient	gradient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
RVSP	RVSP	NN	B-NP	B-protein
before	before	IN	B-PP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
increased	increase	VBN	I-VP	O
at	at	IN	B-PP	O
roughly	roughly	RB	B-ADVP	O
to	to	TO	B-PP	O
55	55	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
.	.	.	O	O

Possible	Possible	JJ	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
gradient	gradient	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
veg	veg	NN	I-NP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
echo	echo	NN	I-NP	O
though	though	IN	B-SBAR	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
tough	tough	JJ	B-ADJP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
given	give	VBN	I-VP	O
her	her	PRP$	B-NP	O
artificial	artificial	JJ	I-NP	O
valve	valve	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
TEE	TEE	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
vegetation	vegetation	NN	B-NP	O
or	or	CC	I-NP	O
thrombus	thrombus	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
thought	think	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
thrombus	thrombus	NN	I-NP	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
already	already	RB	I-VP	O
thrown	throw	VBN	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
OM2	OM2	NN	I-NP	B-protein
would	would	MD	B-VP	O
most	most	RBS	I-VP	O
likely	likely	RB	I-VP	O
be	be	VB	I-VP	O
the	the	DT	B-NP	O
thrombus	thrombus	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
had	have	VBN	I-VP	O
and	and	CC	O	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
none	none	NN	B-NP	O
left	leave	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
valves	valve	NNS	I-NP	O
.	.	.	O	O

For	For	IN	B-PP	O
that	that	DT	B-NP	O
reason	reason	NN	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
volume	volume	NN	B-NP	O
overloaded	overload	VBD	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
diuresed	diurese	VBN	I-VP	O
on	on	IN	B-PP	O
torsemide	torsemide	NN	B-NP	O
100	100	CD	I-NP	O
PO	PO	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
which	which	WDT	B-NP	O
seems	seem	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
as	as	RB	B-ADVP	O
far	far	RB	I-ADVP	O
as	as	IN	B-PP	O
her	her	PRP$	B-NP	O
dry	dry	JJ	I-NP	O
weights	weight	NNS	I-NP	O
seem	seem	VBP	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
around	around	IN	B-NP	O
50	50	CD	I-NP	O
kilos	kilo	NNS	I-NP	O
,	,	,	O	O
maybe	maybe	RB	B-ADVP	O
even	even	RB	B-NP	O
48	48	CD	I-NP	O
kilos	kilo	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
daily	daily	JJ	B-NP	O
weights	weight	NNS	I-NP	O
checked	check	VBD	B-VP	O
.	.	.	O	O

Rhythm-wise	Rhythm-wise	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
A.	A.	NN	B-NP	O
fib	fib	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
events	event	NNS	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
both	both	DT	B-PP	O
for	for	IN	I-PP	O
her	her	PRP$	B-NP	O
valve	valve	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
A.	A.	NN	I-NP	B-protein
fib	fib	NN	I-NP	I-protein
.	.	.	O	O

ID-wise	ID-wise	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
increased	increase	VBN	I-VP	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
shift	shift	NN	I-NP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
band	band	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
lobe	lobe	NN	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
and	and	CC	O	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
7-day	7-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
levo	levo	NN	B-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
afebrile	afebrile	RB	B-ADVP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
again	again	RB	B-ADVP	O
the	the	DT	B-NP	O
negative	negative	JJ	I-NP	O
TEE	TEE	NN	I-NP	O
.	.	.	O	O

Heme-wise	Heme-wise	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
3	3	CD	B-NP	O
to	to	TO	B-PP	O
4	4	CD	B-NP	O
,	,	,	O	O
ideally	ideally	RB	B-NP	O
3	3	CD	I-NP	O
to	to	TO	B-PP	O
3.5	3.5	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
essential	essential	JJ	B-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
5.3	5.3	CD	B-NP	O
on	on	IN	B-PP	O
1/4/04	1/4/04	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
on	on	IN	B-PP	O
3/25/04	3/25/04	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
?	?	.	O	O
?	?	.	O	O
__	__	''	O	B-protein
?	?	.	O	I-protein
?	?	.	O	I-protein
She	She	NNP	B-NP	I-protein
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
VNA	VNA	NN	I-NP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
11/4/04	11/4/04	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
they	they	PRP	B-NP	O
should	should	MD	B-VP	O
call	call	VB	I-VP	O
Coumadin	Coumadin	NNP	B-NP	O
Clinic	Clinic	NNP	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
result	result	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
high	high	JJ	I-NP	O
INR	INR	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
held	hold	VBD	B-VP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NN	I-NP	O
on	on	IN	B-PP	O
10/20	10/20	CD	B-NP	O
and	and	CC	O	O
restarted	restart	VBD	B-VP	O
dose	dose	NN	B-NP	O
on	on	IN	B-PP	O
6/26	6/26	CD	B-NP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
3	3	CD	B-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
Respiratory-wise	Respiratory-wise	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
finished	finish	VBD	B-VP	O
levo	levo	NN	B-NP	O
for	for	IN	B-PP	O
presumed	presume	VBN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
respiratory	respiratory	JJ	I-NP	O
problems	problem	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
complain	complain	VB	I-VP	O
sometimes	sometimes	RB	B-ADVP	O
of	of	IN	B-PP	O
subjective	subjective	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
remained	remain	VBD	B-VP	O
at	at	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
rest	rest	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
besides	besides	IN	B-PP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
cath	cath	NN	I-NP	O
.	.	.	O	O

GI-wise	GI-wise	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
got	get	VBD	B-VP	O
some	some	DT	B-NP	O
simethicone	simethicone	NN	I-NP	O
for	for	IN	B-PP	O
gas	gas	NN	B-NP	B-DNA
and	and	CC	O	O
a	a	DT	B-NP	O
bowel	bowel	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
continued	continued	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	I-NP	O
GI	GI	NN	I-NP	O
and	and	CC	I-NP	O
surgery	surgery	NN	I-NP	O
consulted	consult	VBD	B-VP	O
on	on	IN	B-PP	O
her	her	PRP	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
mesenteric	mesenteric	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
CT	CT	NN	I-NP	O
angiogram	angiogram	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
abdomen	abdomen	NN	I-NP	O
was	be	VBD	B-VP	O
performed	perform	VBN	I-VP	O
with	with	IN	B-PP	O
negative	negative	JJ	B-NP	O
workup	workup	NN	I-NP	O
for	for	IN	B-PP	O
mesenteric	mesenteric	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
thought	think	VBD	B-VP	O
that	that	IN	B-SBAR	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
discomfort	discomfort	NN	I-NP	O
was	be	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
constipation	constipation	NN	B-NP	O
.	.	.	O	O

FEN-wise	FEN-wise	RB	B-ADVP	O
,	,	,	O	O
we	we	PRP	B-NP	O
replaced	replace	VBD	B-VP	O
her	her	PRP$	B-NP	O
lytes	lyte	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
we	we	PRP	B-NP	O
put	put	VBP	B-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
carnitine	carnitine	NN	B-NP	O
for	for	IN	B-PP	O
diet	diet	NN	B-NP	O
supplementation	supplementation	NN	I-NP	O
.	.	.	O	O

Renal-wise	Renal-wise	JJ	B-ADJP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
increase	increase	NN	B-NP	O
in	in	IN	B-PP	O
creatinine	creatinine	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
dye	dye	NN	I-NP	O
load	load	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
cath	cath	NN	I-NP	O
and	and	CC	O	O
both	both	DT	O	O
her	her	PRP$	B-NP	O
CT	CT	NN	I-NP	O
scans	scan	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
.9	.9	CD	B-NP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
held	hold	VBD	B-VP	O
off	off	RP	B-PRT	O
on	on	IN	B-PP	O
starting	start	VBG	B-VP	O
the	the	DT	B-NP	O
ACE	ACE	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
this	this	DT	B-NP	O
,	,	,	O	O
but	but	CC	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
consider	consider	VB	I-VP	O
getting	get	VBG	I-VP	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
to	to	TO	B-VP	O
add	add	VB	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
and	and	CC	I-NP	O
recent	recent	JJ	I-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

That	That	DT	B-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Endocrine-wise	Endocrine-wise	RB	B-ADVP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
really	really	RB	B-NP	O
poor	poor	JJ	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
sugars	sugar	NNS	B-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
40	40	CD	B-NP	O
to	to	TO	B-PP	O
400	400	CD	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
changed	change	VBD	B-VP	O
her	her	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
to	to	TO	B-PP	O
Lantus	Lantus	NNP	B-NP	O
26	26	CD	I-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	RB	B-ADVP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
novalog	novalog	NN	B-NP	O
pre-meal	pre-meal	JJ	B-ADJP	O
with	with	IN	B-PP	O
16	16	CD	B-NP	O
before	before	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	O	O
8	8	CD	B-NP	O
of	of	IN	B-PP	O
novalog	novalog	NN	B-NP	O
before	before	IN	B-PP	O
lunch	lunch	NN	B-NP	O
and	and	CC	O	O
8	8	CD	B-NP	O
of	of	IN	B-PP	O
novalog	novalog	NN	B-NP	O
before	before	IN	B-PP	O
dinner	dinner	NN	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
sugars	sugar	NNS	I-NP	O
improved	improve	VBD	B-VP	O
greatly	greatly	RB	B-ADVP	O
,	,	,	O	O
all	all	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
100s	100	NNS	I-NP	B-DNA
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
severe	severe	JJ	B-NP	O
osteoporosis	osteoporosis	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
and	and	CC	O	O
vitamin	vitamin	NN	B-NP	O
C	C	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
starting	start	VBG	I-VP	O
Zometa	Zometa	NNP	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
per	per	IN	B-PP	O
primary	primary	JJ	B-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Cuaresma	Cuaresma	NNP	I-NP	O
Prophylaxis	Prophylaxis	NNP	I-NP	O
with	with	IN	B-PP	O
heparin	heparin	NN	B-NP	O
and	and	CC	I-NP	O
Nexium	Nexium	NN	I-NP	O
.	.	.	O	O

DISPO	DISPO	NN	B-NP	B-protein
:	:	:	O	O
She	She	PRP	B-NP	O
refused	refuse	VBD	B-VP	O
rehab	rehab	NN	B-NP	O
and	and	CC	O	O
wanted	want	VBD	B-VP	O
to	to	TO	I-VP	O
go	go	VB	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
services	service	NNS	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
should	should	MD	B-VP	O
get	get	VB	I-VP	O
home	home	NN	B-NP	O
PT	PT	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
home	home	NN	I-NP	O
VNA	VNA	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

PLAN	PLAN	NN	B-NP	O
:	:	:	O	O
Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Coumadin	Coumadin	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
and	and	CC	O	O
get	get	VB	B-VP	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
drawn	draw	VBN	B-VP	O
every	every	DT	B-NP	O
2-3	2-3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
VNA	VNA	NN	I-NP	B-protein
should	should	MD	B-VP	O
call	call	VB	I-VP	O
107-568-5779	107-568-5779	CD	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
goal	goal	NN	I-NP	O
again	again	RB	B-ADVP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	B-protein
of	of	IN	B-PP	O
3-4	3-4	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Waley	Waley	NNP	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
1-2	1-2	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Jason	Jason	NNP	I-NP	O
Sorto	Sorto	NNP	I-NP	O
will	will	MD	B-VP	O
come	come	VB	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
her	her	PRP	B-NP	O
on	on	IN	B-PP	O
3/2	3/2	CD	B-NP	O
,	,	,	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
house	house	NN	I-NP	O
.	.	.	O	O

I	I	PRP	B-NP	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
patient	patient	NN	B-NP	O
not	not	RB	O	O
add	add	VB	B-VP	O
salt	salt	NN	B-NP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
diet	diet	NN	I-NP	O
and	and	CC	O	O
not	not	RB	B-VP	O
drink	drink	VB	I-VP	O
fluids	fluid	NNS	B-NP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
one	one	CD	I-NP	O
liter	liter	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-VP	O
check	check	VB	I-VP	O
her	her	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Enteric	Enteric	JJ	B-NP	O
coated	coated	JJ	I-NP	O
aspirin	aspirin	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Folate	Folate	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Ativan	Ativan	IN	B-PP	O
0.25	0.25	CD	B-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	B-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Nitroglycerin	Nitroglycerin	NN	B-NP	O
0.4	0.4	CD	I-NP	O
1/150	1/150	CD	I-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
sublingual	sublingual	JJ	I-NP	O
q.	q.	NN	I-NP	O
5	5	CD	B-NP	O
minutes	minute	NNS	I-NP	O
x3	x3	CD	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
chest	chest	NN	I-NP	O
or	or	CC	O	O
neck	neck	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	B-protein
5-10	5-10	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
q.	q.	NN	I-NP	I-protein
6	6	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
p.r.n.	p.r.n.	JJ	B-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Ocean	Ocean	JJ	B-NP	O
spray	spray	NN	I-NP	O
sodium	sodium	NN	I-NP	O
chloride	chloride	NN	I-NP	O
0.65	0.65	CD	B-NP	O
%	%	NN	I-NP	O
two	two	CD	B-NP	O
sprays	spray	NNS	I-NP	O
q.i.d.	q.i.d.	VBP	B-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
congestion	congestion	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
3	3	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
again	again	RB	B-VP	O
starting	start	VBG	I-VP	O
on	on	IN	B-PP	O
4/18	4/18	CD	B-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Caltrate	Caltrate	NN	B-NP	O
Plus	Plus	CC	I-NP	O
Vitamin	Vitamin	NN	I-NP	O
D	D	NN	I-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
PO	PO	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Maalox	Maalox	NNP	B-NP	O
1-2	1-2	CD	I-NP	O
tabs	tab	NNS	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
6	6	CD	B-NP	O
hours	hour	NNS	I-NP	O
p.r.n.	p.r.n.	VBP	B-VP	O
upset	upset	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.	q.	NN	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Combivent	Combivent	NNP	B-NP	O
two	two	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
q.i.d.	q.i.d.	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Torsemide	Torsemide	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Lactulose	Lactulose	RB	B-NP	O
30	30	CD	I-NP	O
ml	ml	NN	I-NP	O
PO	PO	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

17	17	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
26	26	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

q.p.m.	q.p.m.	RB	B-NP	O
18	18	CD	I-NP	O
.	.	.	O	O

Novalog	Novalog	NNP	B-NP	O
16	16	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

AC	AC	NN	B-NP	O
before	before	IN	B-PP	O
breakfast	breakfast	NN	B-NP	O
,	,	,	O	O
novalog	novalog	NN	B-NP	O
8	8	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

AC	AC	NN	B-NP	O
before	before	IN	B-PP	O
lunch	lunch	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
novalog	novalog	NN	B-NP	O
8	8	CD	I-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	I-NP	O
.	.	.	O	O

AC	AC	NN	B-NP	O
before	before	IN	B-PP	O
dinner	dinner	NN	B-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-2318613	0-2318613	CD	B-NP	O
MCSSten	MCSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Jonas	Jonas	NNP	B-NP	O
Vespia	Vespia	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Vale	Vale	NNP	I-NP	O
Ence	Ence	NNP	I-NP	O
Min	Min	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
SCHUMMER	SCHUMMER	NN	B-NP	O
,	,	,	O	O
FELIX	FELIX	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
PEDRO	PEDRO	NNP	B-NP	O
TOD	TOD	NNP	I-NP	O
FALKENTHAL	FALKENTHAL	NNP	I-NP	O
,	,	,	O	O
MD	MD	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0419329	0419329	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
1/12/04	1/12/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
1/12/04	1/12/04	CD	B-NP	O

